Chiquette E, Toth PP, Ramirez G, Cobble M, Chilton R: Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
In addition, A has a tertiary structure similar to that of insulin, peripheral A acts as a negative regulator of insulin secretion, and there can be interactions between A and insulin signaling (You et al., 2022)
Both clock in around 1819 mg per ounce , nearly double Monsters concentration, not just double the total
Along the lines of GLP-1 analogs and DPP-4 inhibitors, various agonists of GPR40 and GPR120 have been developed and proven effective in ameliorating glycemic control in animal trials (21, 22), now being in phase I or II clinical trials for the treatment of T2D (23)